文献速递淋巴瘤白血病

增强子分析鉴定成人T细胞白血病的 critical 癌基因并刻画细胞身份

Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.
PubMed 文献 · Blood · 2017-10-04

本研究对成人T细胞白血病/淋巴瘤(ATL)原代白血病样本进行增强子分析,发现超级增强子富集于T细胞活化通路基因及已知癌基因位点,并鉴定出与所有ATL样本相关的TIAM2;CDK7抑制剂THZ1可抑制ATL细胞生长并诱导凋亡。

要点

  • ATL与正常成熟T细胞共享T细胞活化通路超级增强子,反映白血病细胞起源。
  • CCR4、PIK3R1、TP73等癌基因位点在多个ATL样本具超级增强子,正常T细胞无。
  • TIAM2与所有ATL样本超级增强子相关,敲低诱导凋亡,过表达促进生长。

核心结论

  • 增强子分析可鉴定ATL的关键癌基因并刻画细胞身份,为识别关键癌基因提供新策略。

研究设计与样本

  • 研究对成人T细胞白血病/淋巴瘤(ATL)原代白血病样本进行增强子分析,ATL为遗传异质性难治性癌症。

主要发现

  • ATL与正常成熟T细胞的超级增强子均富集于T细胞活化通路基因,包括IL2RA/CD25、CD30和FYN。
  • 多个ATL样本在CCR4、PIK3R1和TP73等已知癌基因位点存在超级增强子,正常成熟T细胞无。
  • 小分子CDK7抑制剂THZ1有效抑制ATL细胞生长、诱导凋亡并下调超级增强子相关基因表达。
  • 增强子分析结合基因表达分析鉴定出TIAM2,与所有ATL样本的超级增强子相关,正常T细胞无。
  • 敲低TIAM2诱导ATL细胞系凋亡,过表达TIAM2促进细胞生长。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A number of studies have recently demonstrated that super-enhancers, which are large cluster of enhancers typically marked by a high level of acetylation of histone H3 lysine 27 and mediator bindings, are frequently associated with genes that control and define cell identity during normal development. Super-enhancers are also often enriched at cancer genes in various malignancies. The identification of such enhancers would pinpoint critical factors that directly contribute to pathogenesis. In this study, we performed enhancer profiling using primary leukemia samples from adult T-cell leukemia/lymphoma (ATL), which is a genetically heterogeneous intractable cancer. Super-enhancers were enriched at genes involved in the T-cell activation pathway, including IL2RA/CD25, CD30, and FYN, in both ATL and normal mature T cells, which reflected the origin of the leukemic cells. Super-enhancers were found at several known cancer gene loci, including CCR4, PIK3R1, and TP73, in multiple ATL samples, but not in normal mature T cells, which implicated those genes in ATL pathogenesis. A small-molecule CDK7 inhibitor, THZ1, efficiently inhibited cell growth, induced apoptosis, and downregulated the expression of super-enhancer-associated genes in ATL cells. Furthermore, enhancer profiling combined with gene expression analysis identified a previously uncharacterized gene, TIAM2, that was associated with super-enhancers in all ATL samples, but not in normal T cells. Knockdown of TIAM2 induced apoptosis in ATL cell lines, whereas overexpression of this gene promoted cell growth. Our study provides a novel strategy for identifying critical cancer genes.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Wong RWJ, Ngoc PCT, Leong WZ, et al. Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia. Blood. 2017. PMID: 28978570. doi:10.1182/blood-2017-06-792184

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。